Mechanisms of worsening in progressing stroke: From the laboratory to the clinical setting

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue SUPPL. A, 1997, Pages 65-67

  Davalos A ^a  

^a Josep Trueta University Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CALCIUM CHANNEL; EXCITATORY AMINO ACID; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; GLYCINE; NEUROPROTECTIVE AGENT; NEW DRUG; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL;

BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN NECROSIS; CONFERENCE PAPER; HUMAN; NEUROPROTECTION; NONHUMAN; STROKE;

ANIMALS; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; HUMANS;

EID: 0030819724     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Ginsberg, M.D. Injury mechanisms in the ischemic peumbra- Approaches to neuroprotection in acuse ischemic stroke. Cerebrovasc Dis 1997, 7(suppl 2):7-12.
2. Marchal, G., Beaudouin, V., Rioux, P., et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke. A correlative PET-CT study with voxel-based data analysis. Stroke 1996, 27: 599-606.
3. Rothman, S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986, 19: 105-11.
4. Morimoto, T., Globus, M.Y-T., Busto, R., Martinez, E., Ginsberg, M.D. Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1996, 16: 92-99.
5. Reif, D.W. Ferritin as a source of iron for oxidative damage. Free Radical Biol Med 1992, 12: 417-27.
6. Patt, A., Horesh, I.R., Berger, E.M., Harken, A.H., Repine, J.E. Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains. J Pediatr Surg 1990, 25: 224-28.
7. Chan, P.H. Role of oxidante in ischemic brain damage. Stroke 1996, 1124-29.
8. Du, C., Hu, R., Csernansky, C.A., Hsu, C.Y., Choi, D.W. Very delayed infarction after mild focal cerebral ischemia - a role for apoptosis. J Cereb Blood Flow Metab 1996, 16: 195-201.
9. Bullock, R., Zauner, A., Woodward, J., Young, H.F. Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke 1995, 26: 2187-89.
10. Castillo, J., Dávalos, A., Naveiro, J., Noya M. Neuroexcitatory amino acids and their relationship to infarct size and neurological deficit in ischemic stroke. Stroke 1996, 27: 1060-65.
11. Castillo, J., Dávalos, A., Noya, M. Progression of ischemic stroke and excitotoxic aminoacids. Lancet 1997, 349: 79-83.
12. Dávalos, A., Fernandez-Real, J.M., Ricart, W., et al. Ironrelated damage in acuse ischemic stroke. Stroke 1994, 25: 1543-46.
13. Castillo, J., Dávalos, A., Armengou, A., Noya, M. Cerebrovasc Dis 1997, 7 (suppl 4): 82. Abst.
14. Dávalos, A., Castillo, J., Serena, J., Noya, M. Duration of glutamate release after acute ischemic stroke. Stroke 1997, 28: 708-10.